Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-07-18

FDA Approved: OLMESARTAN MEDOXOMIL — Original Application (Lifestar Pharma LLC)

View source ↗

Summary

FDA approved an original-application (ANDA) for olmesartan medoxomil from Lifestar Pharma LLC, expanding generic availability for hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLMESARTAN MEDOXOMIL (olmesartan medoxomil)

Snippet

ORIG AP for OLMESARTAN MEDOXOMIL (OLMESARTAN MEDOXOMIL)